Breast cancer is cancer caused by uncontrolled cell growth in breast tissue. In this research, molecular docking has been studied to predict the binding affinity of Gnetin C dan trans-resveratrol as active compounds of melinjo seeds to inhibit breast cancer cells Michigan Cancer Foundation-7 (MCF-7). Molecular docking was performed by autodock-vina. The result indicated that Gnetin C and trans-resveratrol could bind the same amino acid as natural ligan of MCF-7 such as VAL 54B, VAL54B, TYR 55B, TYR 216B, TRP 227B, LEU 306B, LEU 306B, and LEU 306B. The binding affinity of Gnetin C and transresveratrol was -6. and -7.9, respectively, while the natural ligan was -10.0. It means Gnetin C and trans-resveratrol can bind the protein acid of MCF-7, although the docking energy was lower than the natural ligan. Based on this research, Gnetin C and trans-resveratrol are potential anticancer and chemoprevention because they can inhibit some amino acids of cancer cells MCF-7.

1. Y. S. Tor, L. S. Yazan, J. B. Foo, N. Armania, Y. K. Cheah, R. Abdullah, M. U. Imam, N. Ismail, and M. Ismail, “Induction of apoptosis through oxidative stress-related pathways in MCF-7, human breast cancer cells, by ethyl acetate extract of dillenia suffruticosa,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, p. 55, 2014. doi: https://doi.org/10.1186/1472-6882-14-55
2. Y. P. C. Anindita, C. R. Marchira, and Y. S. Pra-bandari, “The relationship between the provision of radiotherapy with the occurrence of distress, anxiety, and depression in breast cancer patients,” Berita Ke-dokteran Masyarakat, vol. 26, no. 1, pp. 1–6, 2010. doi: https://doi.org/10.22146/bkm.3475
3. E. I. Putri, R. Magdalena, and L. Novamizanti, “Thedetection of cervical cancer disease using an adaptive thresholding method through digital image processing,” Journal of Advances in Health and Medical Sciences, vol. 1, no. 1, pp. 30–36, 2015. doi: https://doi.org/10.20474/jahms-1.1.4
4. H. Kato, M. Samizo, R. Kawabata, F. Takano, and T. Ohta, “Stilbenoids from the melinjo (gnetum gnemon l.) fruit modulate cytokine production in murine peyer’s patch cells ex vivo,” Planta Medica, vol. 77, no. 10, pp. 1027–1034, 2011. doi: https://doi.org/10.1055/s-0030-1250742
5. S. Ekins, J. Mestres, and B. Testa, “In silico pharmacology for drug discovery: Methods for virtual ligand screening and profiling,” British Journal of Pharmacology, vol. 152, no. 1, pp. 9–20, 2007. doi: https://doi.org/10.1038/sj.bjp.0707305
6. A. N. Jain, “Bias, reporting, and sharing: Computational evaluations of docking methods,” Journal of Computer-aided Molecular Design, vol. 22, no. 3-4, pp. 201–212, 2008. doi: https://doi.org/10.1007/s10822-007-9151-x
7. S. Boonvarasatit, A. Koontalay, and P. Vorasiha, “The experience of cancer survivors to life after cancer,” Journal of Advances in Health and Medical Sciences, vol. 2, no. 3, pp. 92–96, 2016. doi: https://doi.org/10.20474/jahms2.3.2
8. Kharismadhany, U. E. Sari, and Q. A. Rakhmah, “Increasing womenâA ̆ Zs awareness on the impor- tance of early detection of cervical cancer through socialization method and focus group discussion in Sabdodadi village Bantul Yogyakarta,” Journal of Advances in Health and Medical Sciences, vol. 3, no. 1, pp. 9–16, 2017. doi: https://doi.org/10.20474/jahms3.1.2
9. E. Suryaningsih and B. E. Sukaca, Complete Breast Cancer. Yogyakarta, Indonesia: Paradigma Indonesia, 2009.
10. S. Niha, B. Jantarasiriput, N. Tonyongdalaw, andN. Vaichompu, “Reproductive health among ban-goebadae muslim women: Cervical cancer care,” International Journal of Health and Medical Sciences, vol. 2, no. 3, pp. 52–57, 2016. doi: https://doi.org/10.20469/ijhms.2.30002-3
11. C. Panis et al., “Differential oxidative status andimmune characterization of the early and advanced stages of human breast cancer,” Breast Cancer Research and Treatment, vol. 133, no. 3, pp. 881–888, 2012. doi: https://doi.org/10.1007/s10549-011-1851-1
12. N. K. Narayanan, K. Kunimasa, Y. Yamori, M. Mori, H. Mori, K. Nakamura, G. Miller, U. Manne, A. K. Tiwari, and B. Narayanan, “Antitumor activity of melinjo (gnetum gnemon l.) seed extract in human and murine tumor models in vitro and in a colon-26 tumor-bearing mouse model in vivo,” Cancer Medicine, vol. 4, no. 11, pp. 1767–1780, 2015. doi: https://doi.org/10.1002/cam4.520
13. M. Yanagihara, M. Yoshimatsu, A. Inoue, T. Kanno, T. Tatefuji, and K. Hashimoto, “Inhibitory effect of gnetin c, a resveratrol dimer from melinjo (gne-tum gnemon), on tyrosinase activity and melanin biosynthesis,” Biological and Pharmaceutical Bulletin, vol. 35, no. 6, pp. 993–996, 2012. doi: https://doi.org/10.1248/bpb.35.993
14. D. Akrimah and A. Musadad, “Docking of potent anticancer agents; 4-(pyrazol-4yl)-pyrimidine derivatives as selective cyclin-dependent kinase 4/6 inhibitors,” International Journal of Chemical Engineering and Applications, vol. 4, no. 6, pp. 419–422, 2013. doi: https://doi.org/10.7763/ijcea.2013.v4.338

Romadhona, K. N., Shifa, N. A., & Djalil, A. D. (2018). Molecular docking of gnetin c and transresveratrol of melinjo seeds (gnetum gnemon l.) used as the inhibitors of breast cancer cells MCF-7. International Journal of Health and Medical Sciences, 4(3), 58–63. doi:https://doi.org/10.20469/ijhms.40001-3